Dipen Rajgor1, Catherine M Shanahan. 1. James Black Centre, Cardiovascular Division, King's College London, 125 Coldharbour lane, London SE5 9NU, UK.
Abstract
Nuclear envelope spectrin-repeat proteins (Nesprins), are a novel family of nuclear and cytoskeletal proteins with rapidly expanding roles as intracellular scaffolds and linkers. Originally described as proteins that localise to the nuclear envelope (NE) and establish nuclear-cytoskeletal connections, nesprins have now been found to comprise a diverse spectrum of tissue specific isoforms that localise to multiple sub-cellular compartments. Here, we describe how nesprins are necessary in maintaining cellular architecture by acting as essential scaffolds and linkers at both the NE and other sub-cellular domains. More importantly, we speculate how nesprin mutations may disrupt tissue specific nesprin scaffolds and explain the tissue specific nature of many nesprin-associated diseases, including laminopathies.
Nuclear envelope spectrin-repeat proteins (Nesprins), are a novel family of nuclear and cytoskeletal proteins with rapidly expanding roles as intracellular scaffolds and linkers. Originally described as proteins that localise to the nuclear envelope (NE) and establish nuclear-cytoskeletal connections, nesprins have now been found to comprise a diverse spectrum of tissue specific isoforms that localise to multiple sub-cellular compartments. Here, we describe how nesprins are necessary in maintaining cellular architecture by acting as essential scaffolds and linkers at both the NE and other sub-cellular domains. More importantly, we speculate how nesprin mutations may disrupt tissue specific nesprin scaffolds and explain the tissue specific nature of many nesprin-associated diseases, including laminopathies.
The eukaryotic cytoplasm contains three major types of cytoskeletal filaments:
Filamentous-actin (F-actin), microtubules (MTs) and intermediate filaments (IFs). These
components are organised in a manner that provides the cell with an internal framework
fundamental for many processes, such as controlling cellular shape, polarity, adhesion and
migration, cytokinesis, inter- and intracellular communication and trafficking of organelles,
vesicles, proteins and RNA (Refs 1, 2).For cells to utilise the cytoskeleton in these processes, scaffold or linker proteins are
required to attach cytosolic components to these dynamic filaments. The spectrin-repeat (SR)
family of proteins are a prime example of such linkers. The majority of family members are
typically characterised by a pair of N-terminal calponin homology domains (CHDs) that bind
F-actin, followed by a rod-like structure composed of multiple SRs. A single SR is composed of
three α-helical bundles with a left-handed twist, and its primary function is to provide
docking sites for proteins and other higher order complexes (Refs 3, 4). Although most SR proteins
contain CHDs, some possess motifs which can interact with other cytoskeletal components,
allowing linkage of SR-associated complexes to filamentous structures other than F-actin. In
addition, these motifs allow cross-linking between different filaments and dynamic
re-modelling of the cells internal framework in response to altered mechanical needs (Refs
5, 6, 7). The SR family is composed of a growing list of
proteins that include α-actinins, α/β-spectrins, dystrophins and spectraplakins. Family
members are distinguished by unique structural domains, which give the individual family
members their specialised functions. For example, the C-terminal Pleckstrin Homology domain of
β-spectrins facilitate membrane attachment to the cell surface and organelles, the WW and
Zn-fingers of dystrophins associate with the dystroglycan complex spanning the plasma membrane
to provide extracellular matrix attachment and the GAR domains of spectraplakins associate
with MTs and act as cytoskeletal cross-linkers (Refs 8, 9, 10, 11, 12, 13).uclear nvelope pectrin-repeat ote (Nesprins), are the latest members of the SR super family to be identified. They
contain a unique evolutionary conserved C-terminal Klarsicht,
ANC-1 and Syne Homology
(KASH) transmembrane domain that specifically recruits the nesprins to the nuclear envelope
(NE). To date, four separate nesprin genes have been identified in vertebrates, which encode
proteins with distinct cellular functions. Nesprin-1 and nesprin-2 are the largest SR proteins
with molecular weights of ~1000 and ~800 kDa, respectively, and connect the NE to F-actin
through their pair of N-terminal CHDs. Nesprin-3 and nesprin-4, with molecular weights of ~110
and ~42 kDa, respectively, lack N-terminal CHDs (Refs 14, 15, 16, 17). Instead, nesprin-3 contains a
plectin-binding domain which links the NE to the cytoplasmic IF networks. Nesprin-4 associates
with kif5b, a subunit of the MT motor protein kinesin-1, downstream of its single SR (Refs
16, 17)
(Fig. 1). The ability of the nesprins to localise to
the NE and interact with cytoskeletal proteins, initially led to the assumption that their
primary purpose was to act as cytoskeletal-NE linkers. Excitingly, recent developments in
nesprin biology have identified an expansive collection of tissue specific nesprin-1 and
nesprin-2 isoforms generated through alternative transcription (Ref. 18). Many of these isoforms exclude the C-terminal KASH domain and
localise to various sub-cellular compartments, supporting additional functions for nesprins
other than NE linkage.
Figure 1.
The nesprin family. The nesprin family is composed of four members, all of
which contain a C-terminal nuclear envelope (NE) targeting
Klarsicht, ANC-1 and
Syne Homology (KASH) domain, and one or
more spectrin-repeats (SRs). Nesprin-1 contains 74 SRs and binds to F-actin through its
N-terminal calponin homology domains (CHDs). The shorter nesprin-2 protein is composed
of 56 SRs, and like nesprin-1 is able to bind F-actin through its N-terminal CHDs.
Nesprin-3 contains 8 SRs and interacts with the versatile cytoskeletal cross-linker
plectin in a manner that allows nesprin-3 to associate with intermediate filaments
(IFs). Nesprin-4 possesses only a single SR and interacts with kif5b, a subunit of the
microtubule (MT) motor kinesin-1.
The nesprin family. The nesprin family is composed of four members, all of
which contain a C-terminal nuclear envelope (NE) targeting
Klarsicht, ANC-1 and
Syne Homology (KASH) domain, and one or
more spectrin-repeats (SRs). Nesprin-1 contains 74 SRs and binds to F-actin through its
N-terminal calponin homology domains (CHDs). The shorter nesprin-2 protein is composed
of 56 SRs, and like nesprin-1 is able to bind F-actin through its N-terminal CHDs.
Nesprin-3 contains 8 SRs and interacts with the versatile cytoskeletal cross-linker
plectin in a manner that allows nesprin-3 to associate with intermediate filaments
(IFs). Nesprin-4 possesses only a single SR and interacts with kif5b, a subunit of the
microtubule (MT) motor kinesin-1.This review focuses on summarising recent findings in which scaffolding roles for nesprins
have been identified at the NE, and beyond. Furthermore, we speculate that many of the tissue
specific diseases resulting from nesprin mutations, including cardiac and skeletal muscle
dysfunctions in Emery Dreifuss Muscular Dystrophy (EDMD), cerebellar defects in autosomal
recessive cerebellar ataxia 1 (ARCA1), tendon contractures in autosomal recessive
arthrogryposis multiplex congenita (AMC), cardiac defects in dilated cardiomyopathy (DCM) and
major depression in bipolar disease, maybe a consequence of defects in the production or
scaffolding functions of a subset of tissue specific nesprin isoforms, and thus, in some
instances, be completely independent of NE-cytoskeletal linkage (Refs 19, 20, 21, 22, 23).
Nesprins link the NE to the cytoskeleton and nuclear lamina
The nucleus is surrounded by a system of two concentric membranes, called the inner nuclear
membrane (INM) and the outer nuclear membrane (ONM). Together, these two membranes make up
the NE and separate the cells nuclear contents from the cytosol. Although the ONM and INM
are a single continuous joint membrane, perforated by nuclear pore complexes and separated
by a lumen, macromolecular compositions of the two sides vary. The ONM has a similar
composition to that of the adjoined endoplasmic reticulum, with the addition of full-length
nesprins-1, -2, -3 and -4 that link the NE to components of the cytoskeleton (Refs 15, 16, 17). The INM hosts a unique collection of transmembrane
proteins, which link the INM to the underlying nuclear lamina and chromatin (Refs 24, 25, 26, 27, 28).At the NE, the C-terminal sequence of nesprin KASH domains bind to the C-terminal end of
the trimeric INM SUN (ad1p-C-84) domain proteins, SUN1 and SUN2, within the NE lumen (Refs 29, 30). The
N-terminal tail of the trimeric SUN proteins interacts with the nuclear lamina underlying
the nuclear interior (Refs 29, 31, 32). The
nuclear lamina, composed of type-V IF lamin proteins, forms a mechanical fibrous cage around
the interior surface of the NE which provides structural support to the nucleus and
scaffolds nuclear signalling proteins, transcription factors and chromatin (Refs 24, 27, 28). This double membrane spanning complex, mediated by
SUN-KASH bridges, links the cytoskeleton to the nucleoskeleton and is referred to as the
‘linker of nucleoskeleton to cytoskeleton’ (LINC) complex (Refs 30, 31, 32, 33, 34, 35) (Fig. 2). Small nesprin KASH variants generated through alternative
transcription, such as nesprin-1α and nesprin-2β, are potentially capable of NE entry and
are embedded within the INM. At the INM, their SRs project towards the nuclear lamina where
they interact strongly with lamin A/C, emerin and signal transducers including mAKAP (Refs
19, 36,
37, 38).
Rather than binding to the C-terminal SUN domain of the SUN proteins, these short KASH
variants are likely to interact with sequences closer to the N-terminus, as shown with
nesprin-2, which appears to have an overlapping binding site with emerin in SUN1 (Refs 31, 39).
Figure 2.
Nesprins link the nucleoskeleton to components of the cytoskeleton. The
linker of nucleoskeleton to cytoskeleton (LINC) complexes couples the nuclear lamina
to cytoskeletal networks via the nesprins. The LINC complex is comprised of SUN (ad1p-C-84) domain containing proteins, which exist as trimers, in the inner
nuclear membrane (INM) and associate with the nuclear lamina via interactions with the
lamin proteins, emerin and small INM nesprin isoforms. The
Klarsicht, ANC-1 and
Syne Homology (KASH) domains of
full-length nesprins-1, nesprin-2, nesprin-3 and nesprin-4 in the outer nuclear
membrane (ONM) bind to the SUN domains of the SUN proteins in a 3:3 KASH:SUN ratio
within the luminal space, and serve to tether the nuclear envelope (NE) to cytoplasmic
F-actin, intermediate filaments (IFs) or microtubules (MTs) respectively. Small KASH
isoforms present within the INM do not interact with the SUN domain of SUN protein.
Instead, they appear to interact with the emerin binding region in SUN proteins via
their spectrin repeats (SRs). NE-cytoskeletal interactions via the LINC complex are
accountable for nuclear anchorage, nuclear positioning, nuclear migration, cell
polarity, cell differentiation, mechanotransduction, nuclear cytoskeletal organisation
and organelle positioning.
Nesprins link the nucleoskeleton to components of the cytoskeleton. The
linker of nucleoskeleton to cytoskeleton (LINC) complexes couples the nuclear lamina
to cytoskeletal networks via the nesprins. The LINC complex is comprised of SUN (ad1p-C-84) domain containing proteins, which exist as trimers, in the inner
nuclear membrane (INM) and associate with the nuclear lamina via interactions with the
lamin proteins, emerin and small INM nesprin isoforms. The
Klarsicht, ANC-1 and
Syne Homology (KASH) domains of
full-length nesprins-1, nesprin-2, nesprin-3 and nesprin-4 in the outer nuclear
membrane (ONM) bind to the SUN domains of the SUN proteins in a 3:3 KASH:SUN ratio
within the luminal space, and serve to tether the nuclear envelope (NE) to cytoplasmic
F-actin, intermediate filaments (IFs) or microtubules (MTs) respectively. Small KASH
isoforms present within the INM do not interact with the SUN domain of SUN protein.
Instead, they appear to interact with the emerin binding region in SUN proteins via
their spectrin repeats (SRs). NE-cytoskeletal interactions via the LINC complex are
accountable for nuclear anchorage, nuclear positioning, nuclear migration, cell
polarity, cell differentiation, mechanotransduction, nuclear cytoskeletal organisation
and organelle positioning.Through hetero- and homo-oligomerisation events that occur between the SUN domains and
nesprin proteins, LINC complexes form higher order structures that are more complex than
originally anticipated. Recent crystallisation studies illustrate that the SUN domain of
SUN2 forms a trimeric structure and interacts with 3 independent KASH proteins in a 3:3
stoichiometry ratio (Ref. 29). Although these
oligomeric structures are yet to be proved in vivo, hypothetically any one
of the many ONM nesprin variants (see below) could associate in any combination with a
trimer of SUN domain proteins, allowing a large and mixed plethora of LINCs to form.Nesprin-1α, which is enriched in cardiac, skeletal and smooth muscle, forms anti-parallel
homodimers within the INM (Ref. 36). The
significance of this dimerisation event remains unclear, but may provide additional
mechanical strength to nuclei that are constantly exposed to contractile strain, by forming
complex connections with the underlying nuclear lamina and other interacting partners.In addition, nesprin-1 and nesprin-2 giants (i.e. full-length nesprin-1 and nesprin-2
isoforms) dimerise with nesprin-3 at the ONM to form a meshwork composed of peri-nuclear
cytoskeletal filaments around the nuclear periphery, which becomes disorganised when nesprin
LINCS are disrupted (Refs 40, 41, 42). This meshwork may
supply the necessary framework and act as a cushion for LINC complex functions that put
considerable strain on the nucleus through force transmission. For example, the meshwork may
function as a buffer from physical forces generated through nuclear migration or
transduction of mechanical stimuli generated within the cell or from the extracellular
environment. Besides nuclear migration and mechanotransduction, nesprin LINC complexes are
required for cellular differentiation, synchronising the localisation of cytosolic
organelles, aiding in establishing cell polarity and participating in cell migration,
suggesting that they are central for precise coordination and organisation of the entire
cell (Refs 17, 35, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53). Indeed, emerging evidence now strongly supports the cell as a structurally
coupled system, with perturbations in mechanical stimuli influencing nuclear organisation,
epigenetics and mechanotransduction through nesprin LINC complexes (Refs 54, 55, 56, 57).
Heterogeneity of nesprins in the LINC complex
Hypothetically, up to 16 nesprin-1 and 12 nesprin-2 KASH isoforms can be generated by
alternatively combining identified 5′UTRs with the 3′UTRs of the nesprin-1 and nesprin-2
giant full-length variants, which terminate after inclusion of the KASH domain (Fig. 3). Interestingly, the recently identified tissue
specific expression of nesprin 5′UTRs implies that different cells and tissues are likely to
express different KASH isoforms; although expression of many of the large variants need to
be validated (Ref. 18). Early Northern blotting
experiments using probes to target the C-terminal region of nesprin-1 and nesprin-2 detected
multiple sized transcripts in a tissue specific manner, supporting the existence of multiple
KASH isoform transcripts (Refs 14, 58). This is consistent with proteomic analysis
demonstrating variations in the NE proteome in different tissues (Ref. 26). Putative tissue specific nesprin KASH isoforms vary in size from
~53 kDa of p53KASHNesp1 to ~1000 kDa of the nesprin-1 giant for nesprin-1, and
~48 kDa of nesprin-2α2 to ~800 kDa of the nesprin-2 giant for nesprin-2. The
large KASH isoforms are expected to localise at the ONM because of size restriction of
protein transport across the NE, however the smaller variants are probably capable of
embedding within either membrane. KASH isoforms that lack the CHDs may expose additional
isoform specific N-terminal SR binding motifs, which could tether transcription factors or
other nuclear signalling proteins for INM isoforms, or cytoskeletal components such as motor
proteins for ONM isoforms. In addition, nesprins may also participate in tethering
organelles to the nuclear membrane and in organelle organisation (Ref. 53). Theoretically, any three KASH isoforms could form bridges in a
variety of different combinations with a single SUN domain trimer. Together, these nesprins
could function in tethering tissue specific components to the NE, determined by a cells
unique nesprin-KASH isoform profile and their SUN–KASH combinations. Their unique anchoring
functions may influence or adapt nuclear mechanical stability, stiffness, positioning and
migration, as well as cell polarity and cellular signalling pathways for tissue specific
functions.
Figure 3.
Potential nesprin-1 and nesprin-2 By combining all the
identified 5′UTRs with the nesprin-1 giant and nesprin-2 giant 3′UTRs, up to 16
different nesprin-1 and 12 different nesprin-2 KASH domain-containing variants can be
created. Although many of the large variants are hypothetical and yet to be validated
at the mRNA and protein level, the tissue specific expression of the 5′UTRs suggests
that they are likely to be highly tissue specific. Furthermore, the exposure of unique
N-terminal binding motifs generated through alternative initiation suggests that each
variant may scaffold unique protein complexes to the nuclear envelope (NE).
Potential nesprin-1 and nesprin-2 By combining all the
identified 5′UTRs with the nesprin-1 giant and nesprin-2 giant 3′UTRs, up to 16
different nesprin-1 and 12 different nesprin-2 KASH domain-containing variants can be
created. Although many of the large variants are hypothetical and yet to be validated
at the mRNA and protein level, the tissue specific expression of the 5′UTRs suggests
that they are likely to be highly tissue specific. Furthermore, the exposure of unique
N-terminal binding motifs generated through alternative initiation suggests that each
variant may scaffold unique protein complexes to the nuclear envelope (NE).Moreover, nesprin isoform profiles are dynamically regulated during cellular
differentiation and could be fundamental in developmental processes. For example, a switch
from larger KASH isoforms to smaller KASH isoforms is observed during human myotube
differentiation (Ref. 48). This may serve to alter
LINC complex functions, enabling cells to change from a dynamic motile phenotype to a rigid
stable contractile phenotype. During embryonic stem (ES) cell differentiation, the NE lumen
becomes narrower in differentiated cells and nesprin-1 KASH isoforms become significantly
upregulated. Although ES cells did not fail to differentiate when depleted of nesprin-1
using siRNA, their NE lumen failed to narrow and remained similar in size to their
undifferentiated counterparts. This data suggests that dynamic regulation of nesprin-1 KASH
isoforms acts to regulate NE structure during ES cell differentiation and could be important
for maintaining their pluripotent state (Ref. 59).
Nesprins in nuclear anchorage, positioning and migration
Early insights into cytoskeletal-nuclear connections came from studying nesprins in lower
organisms such as Caenorhabditis elegans and Drosophila
melanogaster, which both only posses one nesprin-1/-2 homologue; ANC-1 and
MSP-300 respectively. Mutations in these nesprin homologues or overexpression of dominant
negative constructs affect nuclear anchorage in the hypodermal syncytia of C.
elegans and nurse cells of D. melanogaster, demonstrating the
importance of actin-LINCs in nuclear scaffolding (Refs 53, 60, 61).In mammals, mouse models have been utilised to demonstrate that nuclear anchorage is
mediated by nesprins in vivo. Transgenic mice overexpressing the dominant
negative nesprin-1 KASH domain under the control of a muscle-specific promoter, display a
loss of synaptic nuclear anchorage beneath the neuromuscular junction in skeletal muscle
(Ref. 43). Nesprin-1−/−KASH
domain knockout (KO) mice also demonstrate synaptic nuclei displacement, as well
as additional aggregation of extra-synaptic nuclei. Furthermore, these KO mice display
extensive branching of phrenic nerves, suggesting that nesprin-1 mediated synaptic nuclear
anchorage may be essential for maintaining neuronal innervation sites. On the contrary,
nesprin-2−/−KASH
domain KO mice do not appear to have any nuclear anchorage defects or notable
phenotypes. However, when all actin-LINCs are abolished in nesprin-1−/−KASH
domain and nesprin-2−/−KASH domain double KOs, mice die at birth because of
respiratory failure (Ref. 44). These data suggest
that there may be some redundancy between nesprin-1 and nesprin-2 KASH isoforms, however the
overlapping similarities are yet to be investigated.Although these studies primarily assumed that disruption of actin-LINCs mediated through
nesprin-1 and nesprin-2 giants were responsible for the accompanying phenotypes, they do not
take into consideration the scaffolding function of the other KASH isoforms described in
this review that would also be disrupted (Fig. 3).
Consequently, these animal models may additionally disrupt KASH isoforms that do not form
links exclusively with actin. For example, the interaction between nesprin-1 and nesprin-2
with dynein and kinesin-1 couples the centrosome to the neuronal nucleus in the developing
mouse brain. In nesprin-1−/−KASH domain and nesprin-2−/−KASH domain
double KO mice, the centrosome is uncoupled from the neuronal nuclei, resulting in severe
nucleokinesis and interkinetic nuclear migration defects (Ref. 62). Currently, the binding motifs for these motor proteins have not
been mapped within the nesprin-1 and nesprin-2 proteins. They could interact with the giant
full-length nesprins, or alternatively associate through one of the N-terminal SRs exposed
in any of the truncated KASH domain variants (Fig.
3). Whereas nesprin-4 is only expressed in a selective population of epithelial cells
to drive nuclear migration, alternate nesprin-1 and/or nesprin-2 KASH isoforms could perform
similar functions in other cell types.Interestingly, an SR in the central rod of nesprin-1 also binds to kif3b, a kinesin-2
subunit, and appears to play a role in cytokinesis and membrane transport (Ref. 63). Whether this interaction occurs in specific KASH
containing nesprin-1 variants or KASH-less variants still requires further investigation,
but could link nesprin-1 KASH variants in regulating cytokinesis.
Organelle anchorage and positioning
As well as being key in nuclear anchorage and positioning, nesprin LINCs have been
implicated in the anchorage and positioning of other cytoplasmic organelles. For example,
ANC-1 mediated actin-LINCs in C. elegans have been identified as
mitochondrial scaffolds, where ANC-1 mutants display defective mitochondrial positioning
(Ref. 53). In addition, overexpression of a
dominant negative nesprin-1 Golgi-binding domain causes the Golgi to collapse into condensed
structures near the centrosome in epithelial cells (Ref. 64). However, whether the correct anchorage of these organelles is mediated by
LINC complex nesprins, LINC complex-independent nesprin isoforms, or a combination of both
still remains unknown.
KASH-less nesprin variants localise to multiple subcellular compartments
The existence of nesprin variants in sub-cellular compartments other than the NE was first
observed when antibodies were generated to different domains of nesprin-1 and nesprin-2. The
currently available nesprin-1 and nesprin-2 antibodies localise nesprins to the nucleolus,
stress fibres, focal adhesions, Golgi, Centrosome, nuclear matrix, heterochromatin,
sarcomere, plasma membrane, promyelocytic (PML) bodies, mitochondria and sarcoplasmic
reticulum (Refs 14, 15, 36, 58, 63, 64, 65, 66, 67, 68, 69). Interestingly, some
of these localisations are only observed in specific cell lines, indicating that the
variants localising to these cellular sites are potentially tissue specific. Furthermore,
these variants are likely to lack the KASH domain and be generated through the alternative
combination of the nesprin-1 and nesprin-2 5′UTRs and 3′UTRs. The assortment of nesprin-1
and nesprin-2 transcripts produced through alternative transcription encode a diverse range
of KASH-less variants, which can be further complicated when alternative splicing of the
several cassette exons spread across the nesprin genes are taken into account (Ref. 18). Interestingly, many of these variants are
transcribed in a tissue specific manner and appear to have different sub-cellular
localisations within different cell lines when ectopically expressed. These data support the
cell-specific staining observed with the nesprin antibodies and suggests that individual
isoforms may mediate tissue-specific scaffolding and signalling events.
CHD isoforms
As with the KASH domain nesprin variants, multiple CHD variants can be generated by
combining the full-length nesprin-1 and nesprin-2 giant 5′UTRs with the alternative 3′UTRs
spread across these genes. Alternative transcription would allow the generation of 14
putative nesprin-1 and 5 putative nesprin-2 CHD isoforms, respectively, although expression
of many of the large variants need to be validated (Fig.
4). Given the tendency of the CHDs to associate with F-actin, all these variants
should scaffold cellular components to the actin cytoskeleton (Ref. 66). The tissue specific expression of the CHD variants suggests that
they are likely to play fundamental roles in tissue-specific actin-mediated
signalling/scaffolding events. This may contribute to determining the morphological
structure of different cell lines and potentially regulate how different cells adapt the
actin cytoskeleton for migration and adherence in vivo.
Figure 4.
Potential nesprin-1 and nesprin-2 calponin homology domain (CHD)
variants. By combining all the identified 3′UTRs with the nesprin-1 giant and
nesprin-2 giant 5′UTRs, up to 14 different nesprin-1 and 5 different nesprin-2 CHD
containing variants can be translated. As with the Klarsicht,
ANC-1 and Syne
Homology (KASH) variants in Fig. 3, many of the large variants are hypothetical and yet to be validated
at the mRNA and protein level. However, the tissue specific expression of the 3′UTRs
suggests that these variants are likely to be highly tissue specific. Therefore, the
cells CHD variant expression profile may play a role in determining cell shape, rate
of cell migration and contribute to its actin-mediated signalling/scaffolding
events.
Potential nesprin-1 and nesprin-2 calponin homology domain (CHD)
variants. By combining all the identified 3′UTRs with the nesprin-1 giant and
nesprin-2 giant 5′UTRs, up to 14 different nesprin-1 and 5 different nesprin-2 CHD
containing variants can be translated. As with the Klarsicht,
ANC-1 and Syne
Homology (KASH) variants in Fig. 3, many of the large variants are hypothetical and yet to be validated
at the mRNA and protein level. However, the tissue specific expression of the 3′UTRs
suggests that these variants are likely to be highly tissue specific. Therefore, the
cells CHD variant expression profile may play a role in determining cell shape, rate
of cell migration and contribute to its actin-mediated signalling/scaffolding
events.The involvement of CHD variants in actin mechanics has been identified in
p56CHNesp1 and p32CHNesp2, the only nesprin CHD variants to be fully
cloned and expressed into cells to date (Ref. 18).
p32CHNesp2 expression was limited to leukocytes and U2OS cells, localising to
focal adhesions in the latter and implicating it in cell adhesion and migration.
p56CHNesp1, composed of both nesprin-1 CHDs and a single SR, appears to be
ubiquitously expressed in all tissues and cells examined, however displays differential
localisations in primary and transformed cell lines. In primary human dermal fibroblasts
(HDFs), p56CHNesp1 localised to actin stress fibres, suggesting that it could
scaffold cellular components to actin via its single SR. However, in U2OS cells, the protein
appears to have nuclear functions, based on its nucleolar localisation. The presence of
actin polymers within the nucleus and the structural motifs present in p56CHNesp1
suggest it may function as a nucleolar scaffold in U2OS cells (Refs 70, 71). Nuclear actin appears
to play fundamental roles in transcription mediated by all three RNA polymerases, chromatin
remodelling, pre-mRNA processing and gene movement, implicating p56CHNesp1 in any
number of nuclear actin mediated events (Ref. 72).
The reasons behind the differential sub-cellular localisations currently remains unclear,
but could partially be regulated by heterogeneous availability of the actin cytoskeleton in
different cell types. Embedded within the nesprin-1 CHDs are two nuclear localisation
signals which may be utilised in cells with low F-actin levels, such as U2OS cells, but not
in structural cells such as HDFs where there is abundant cytoplasmic actin available for
binding. Alternatively, p56CHNesp1 could display actin localisation in primary
cells and re-localise to the nucleolus when cells become transformed during cancer
development. Whether this change in localisation results in remodelling of nuclear actin
polymers, resulting in misregulated nuclear-actin processes such as transcription, would
make an interesting hypothesis.Previously, Drop-1, a CHD nesprin-1 isoform composed of multiple SRs, has been identified
as an isoform to be significantly down regulated in multiple cancers (Ref. 73). This study, along with the localisation changes
observed with p56CHNesp1, highlight that nesprin-1 CHD isoforms may be disrupted
in cancers and could be classified as potential hallmarks of cellular transformation.
SR isoforms
To date, a greater number of alternate 5′UTRs and 3′UTRs have been identified for nesprin-1
relative to nesprin-2, implying nesprin-1 has the potential to generate a greater number of
diverse isoforms. The positioning of the 5′UTRs and 3′UTRs across their genes suggests that
nesprin-2 does not have the capacity to generate SR-only variants to the same extent as
nesprin-1. With the 5′UTRs towards the end of the nesprin-2 gene and the 3′UTRs towards the
beginning, nesprin-2 is more likely to generate KASH domain and CHD variants rather than
those composed solely of SRs (Ref. 18). This
suggests that nesprin-2 is prone to exert scaffolding functions at the NE and function in
scaffolding protein complexes to F-actin rather than play roles in other sub-cellular
compartments. However, by utilising the N2-3′E115 3′UTR or removing exons 111 and 112 by
alternative splicing, two novel mechanisms exist which allow KASH-less and CHD-less
nesprin-2 variants to be created. Indeed, a KASH-less nesprin-2β variant in vascular smooth
muscle cells (VSMCs), likely to be generated through removal of exons 111 and 112 as
detected previously, acts as a nuclear scaffold for ERK1/2 signalling pathways at PML
nuclear bodies (Refs 18, 69). When this complex was disrupted using siRNA-mediated nesprin-2
knockdown, ERK 1/2 was displaced from PML bodies and an enhanced ERK1/2 activity was
observed, resulting in increased proliferation of VSMCs.With nesprin-1 UTRs more randomly scattered along its gene, the combinations of nesprin-1
5′UTRs and 3′UTRs are potentially unlimited and would allow generation of a diverse spectrum
of SR variants with specialised tissue specific scaffolding functions. A 56 kDa
Golgi-localised spectrin-repeat containing protein (GSRP-56) and candidate plasticity gene 2
(CPG2) were the first tissue-specific SR only nesprin-1 variants identified. GSRP-56 was
identified in a yeast-2-hybrid screen as a novel binding partner for transient receptor
potential cation channel, vanilloid family type 2 (TRPV2) (Ref. 68). Endogenous GSRP-56 was detected and labelled the Golgi apparatus
in myoblasts, myotubes and primary cardiomyocytes. When ectopically expressed in HEK293
cells, GSRP-56 formed large aggregates that surrounded the Golgi apparatus and induced Golgi
area expansion, suggesting GSRP-56 may be a scaffold for the Golgi that regulates its
structure (Ref. 68). CPG2 was first identified as a
brain and neuron specific isoform which contributed to the long-term plasticity; the ability
of neurons to stably alter their phenotype in response to various stimuli such as glutamate
receptor activation and exposure to light (Refs 74,
75). Endogenous CPG2 localised to the cytosol, ER
and postsynaptic endocytic zone surrounding dendritic spines in vitro,
suggesting that CPG2 could participate in clathrin-mediated uptake and recycling of
chemokine receptors (Ref. 76). In agreement with
this function, knockdown of CPG2 led to an increase in the number of post-synaptic glutamate
receptors with a concomitant increase of clathrin coated vesicles within dendritic arms,
indicating that CPG2 is necessary for receptor internalisation and vesicle clearance (Ref.
76). Interestingly, knockdown of CPG2 decreased
spine size, implying it may also regulate dendritic spine structure and morphology.More recently, we identified multiple 5′UTRs and 3′UTRs spread between exons 83 and 90 of
the nesprin-1 gene, highlighting it as a hotspot region for the generation of multiple small
nesprin SR isoforms. Indeed, five alternative transcripts could be detected in a tissue
specific manner by alternatively combining the multiple UTRs (Fig. 5) (Ref. 18).
p31Nesp1, p23Nesp1 and p12Nesp1 terminated with the
N1-3′E87 3′UTR and all localised to the nucleolus when transfected into HDFs. Interestingly,
the largest variant, p31Nesp1, localised to the nucleolus without disrupting
nucleolar morphology when transfected into HDFs, whereas the N-terminally truncated
p23Nesp1 and p12Nesp1 caused fibrillarin to re-distribute into
nucleolar cap structures. This data implies p31Nesp1 is a potential nucleolar
scaffold where the N-terminal SRs of the protein are critical for maintaining nucleolar
structure in HDFs, which can be disrupted upon the overexpression of the N-terminally
truncated p23Nesp1 or p12Nesp1 dominant negative isoforms.
Interestingly, these variants were expressed in a tissue-specific manner, with only one of
the three isoforms detected in each of the multiple tissues examined. Although the current
function of these nucleolar isoforms are unknown, their tissue specificity highlights
further the possibility that nesprin isoforms may act to fine tune tissue-specific cellular
functions, including nucleolar functions. In contrast, when transfected into U2OS cells, all
three variants localised diffusively within the cytosol, implying they have no nuclear
functions in certain cell types. The ubiquitously expressed p50Nesp1 localised to
and bundled MTs when transfected into U2OS cells, suggesting it may be a Microtubule
Associated Protein (MAP) capable of linking protein complexes to the MT network and acting
as a MT scaffold.
Figure 5.
Spectrin repeat (SR)-only nesprin-1 isoforms generated from UTRs located
between exons 83 and 90 of the nesprin-1 gene. Nesprin-1 isoforms
p31Nesp1, p23Nesp1, p12Nesp1, p50Nesp1
and p41Nesp1 are isoforms generated through alternative transcription using
the three 5′UTRs and two 3′UTRs located between exons 83 and 90.
Spectrin repeat (SR)-only nesprin-1 isoforms generated from UTRs located
between exons 83 and 90 of the nesprin-1 gene. Nesprin-1 isoforms
p31Nesp1, p23Nesp1, p12Nesp1, p50Nesp1
and p41Nesp1 are isoforms generated through alternative transcription using
the three 5′UTRs and two 3′UTRs located between exons 83 and 90.
Nesprins and disease
Multiple nesprin mutations have been identified that are likely to be included in a
multitude of nesprin isoforms. For example, ARCA1 mutations in the nesprin-1 gene that
produce premature termination codons, are likely to result in truncations of multiple
nesprin isoforms and affect a range of nesprin-associated tissue specific scaffolds (Ref.
20). Similarly, a nesprin-4 mutation resulting in
pre-mature termination has recently been reported to be causal for hearing loss. Disruption
of nesprin-4 LINCs and nuclear migration in hair cells are thought to be the underlying
cause, as shown convincingly with nesprin-4 KO mice (Ref. 77).Mutations in lamin A/C and nesprin-1 have been renowned for causing dominant
cardiomyopathies. A patient with a missense mutation near the KASH domain of nesprin-1
developed severe DCM requiring cardiac transplantation. Fibroblasts from this individual had
increased expression of nesprin-1α and lamins A and C, indicating changes in nuclear lamina
complexes (Ref. 22). These findings mirror what has
been described from lamin A/C mutations, suggesting the importance of an intact nuclear
lamina and LINC complex for a normal functioning heart (Ref. 78).Heterozygous missense mutations have been identified in nesprin-1 and nesprin-2 when
performing DNA screens on patients with EDMD or EDMD-like phenotypes. Fibroblasts from these
patients exhibited nuclear morphology defects, mislocalised emerin and SUN-2 and impaired
nesprin/emerin/lamin interactions, suggesting defective LINC complexes in these patients are
the underlying cause of EDMD. siRNA-mediated nesprin-1 or nesprin-2 knockdown in normal
fibroblasts reproduced the nuclear morphological changes and mislocalisation of emerin and
Sun-2 observed in patient fibroblasts (Ref. 19).
Later studies demonstrated that one of the nesprin-1 mutant-derived EDMD primary fibroblast
cells were less adhesive, migrated slower in a wound healing assay and were more susceptible
to senescence (Ref. 79). Similar localisation of
emerin and SUN-2 are seen in EDMD patients carrying mutations in the INM transmembrane LUMA
protein (Refs 80, 81). Although no interaction between LUMA and nesprins have been observed, the
possibility of LUMA interacting with smaller KASH isoforms located at the INM is a strong
possibility; especially considering mutations in both proteins cause EDMD and
cardiomyopathies. Point mutations in nesprins are also casual for other diseases including
AMC, ARCA1 and bipolar disease. Therefore, it is not unreasonable to assume that these
patients may have disrupted tissue-specific nesprin scaffolds (Refs 19, 20, 21, 22, 23). Although clearly not understood, nesprins have misregulated
isoform expression in certain cancers, which indicates two things (Refs 73, 82, 83, 84).
Firstly, nesprin associated complexes may be disrupted when other cellular signalling
pathways are hampered, particularly those which control nesprin gene expression. Therefore,
emphasis on identifying signalling pathways which govern gene expression and splicing of
different nesprin isoforms is of utmost importance. Clearly, this is a significant factor,
not only for aiding cancer therapy, but also for cellular differentiation and development
where nesprins change isoform expression profiles (Refs 18, 48, 85). Secondly, nesprin isoform expression could be misregulated in a host of other
diseases of the cardiovascular, muscular and neural systems. Indeed, nesprin-1 and nesprin-2
were originally discovered as two genes to be significantly down regulated in a cDNA screen
when looking for VSMC differentiation markers, indicating a reduction of nesprin expression
in the vasculature may promote atherosclerosis (Refs 14, 86). Therefore, the identification of
isoform specific binding partners are fundamental in providing clues to the potential
nesprin associated complexes and signalling pathways which are disrupted in nesprin
associated diseases.
Concluding remarks and future directions surrounding nesprin biology
Over the last decade, our understanding of nesprins as NE-cytoskeletal couplers has
increased considerably. However, there still remains a large uncertainty about the plethora
of functions for nesprins, particularly now that it is clear they produce a diverse spectrum
of tissue-specific isoforms with scaffolding roles throughout the cell (Fig. 6). To date, only a small number of nesprin isoforms have been
cloned or described. Future work should involve a more in-depth study characterising each of
the individual isoforms by generating appropriate tools such as isoform-specific antibodies
and siRNAs, and suitable KO and transgenic animal models to elucidate the function of the
individual endogenous isoforms in vivo. The lack of isoform specific
sequences in many of the nesprin variants makes it difficult to design antibodies targeting
a single isoform. However, the sequences created through intron run in, to initiate and
terminate groups of nesprin variants, can generate unique N-terminal and C-terminal peptide
sequences absent in the giant full-length variants. These may provide suitable sequences for
generating antibodies for groups of isoforms initiating and terminating with specific sites.
For example, N1-3′E87 and N1-3′E90 terminate with 10 and 8 unique amino acids, respectively,
that are absent in variants terminating with other 3′UTRs. Although this cannot be used to
target any specific isoform, it will drastically reduce the number of isoforms detected when
compared with the current crop of available antibodies. A similar approach will also be
needed for designing siRNAs, where sequences within individual UTRs may need to be targeted.
To date, only a limited number of nesprin animal models have been created, primarily
examining the function of the LINC complex through disruption of KASH variants. Future work
should focus on designing animal models that disrupt KASH-less variants, possibly by
removing exon sequences, which encode for SRs present within the central rod region of
nesprins.
Figure 6.
Nesprins act as linkers and provide scaffolds for multiple sub-cellular
compartments. Traditionally, the nesprins are known for their linker of
nucleoskeleton to cytoskeleton (LINC) complex functions in linking the nuclear
envelope (NE) to components of the cytoskeleton. However, through alternative
transcription the nesprins are capable of generating multiple tissue specific isoforms
that localise to multiple sub-cellular compartments. Klarsicht,
ANC-1 and Syne
Homology (KASH) domain isoforms can localise to the inner
nuclear membrane (INM) and/or the outer nuclear membrane (ONM). At the INM, they
interact with components of the nuclear lamina, including lamin A/C and emerin. On the
ONM, they interact directly or indirectly with all 3 major cytoskeletal filaments;
F-actin (Nesprin-1 and -2), intermediate filaments (IFs) (Nesprin-3 via plectin) and
microtubules (MTs) (Nesprin-4 via kif5b and nesprin-1/-2 via dynein and kinesin-1).
Additional nesprin-1 and nesprin-2 KASH variants on the ONM may link other cytosolic
protein complexes or organelles, such as the Golgi or mitochondria, to the NE.
KASH-less nesprin variants have been identified in multiple cytoplasmic and nuclear
compartments including focal adhesions, F-actin, the Golgi, microtubules,
promyelocytic (PML) bodies and the nucleolus. Question marks represent unidentified
protein complexes, organelles or functions associated with various isoforms.
Nesprins act as linkers and provide scaffolds for multiple sub-cellular
compartments. Traditionally, the nesprins are known for their linker of
nucleoskeleton to cytoskeleton (LINC) complex functions in linking the nuclear
envelope (NE) to components of the cytoskeleton. However, through alternative
transcription the nesprins are capable of generating multiple tissue specific isoforms
that localise to multiple sub-cellular compartments. Klarsicht,
ANC-1 and Syne
Homology (KASH) domain isoforms can localise to the inner
nuclear membrane (INM) and/or the outer nuclear membrane (ONM). At the INM, they
interact with components of the nuclear lamina, including lamin A/C and emerin. On the
ONM, they interact directly or indirectly with all 3 major cytoskeletal filaments;
F-actin (Nesprin-1 and -2), intermediate filaments (IFs) (Nesprin-3 via plectin) and
microtubules (MTs) (Nesprin-4 via kif5b and nesprin-1/-2 via dynein and kinesin-1).
Additional nesprin-1 and nesprin-2 KASH variants on the ONM may link other cytosolic
protein complexes or organelles, such as the Golgi or mitochondria, to the NE.
KASH-less nesprin variants have been identified in multiple cytoplasmic and nuclear
compartments including focal adhesions, F-actin, the Golgi, microtubules,
promyelocytic (PML) bodies and the nucleolus. Question marks represent unidentified
protein complexes, organelles or functions associated with various isoforms.The primary function of nesprins as cellular scaffolds and linkers suggests more needs to
be done in identifying nesprin interacting proteins. To date, many nesprin binding partners
have been identified; however, these are likely to represent only a small proportion of
total interactors. More importantly, most binding partners are yet to be mapped to specific
isoforms. Whether a protein which interacts with a specific SR in one variant is capable of
interacting with the same SR in additional variants is yet to be examined. There is the
possibility that proteins may be unable to bind to a common SR in different variants through
steric hindrance brought about by additional interacting proteins associating with nearby
SRs in some variants. SRs are composed of three α-helical bundles, where the first and last
helices of an SR are also included in the final helix and the first helix of the two
adjacent SRs, respectively. Therefore, depending on which start site is used to generate
individual isoforms, or if any isoforms have altered alternative exon splicing, it is likely
that the α-helical structures utilised in a single SR could be altered in different
variants, leading to a change in strength or abolishment, of protein binding to a common SR.
Therefore, the identification of isoform specific binding partners, either from
yeast-2-hybrid screens or pull-down experiments using exogenous tagged isoforms, is a
necessity if the true extent of nesprin scaffolding is to be elucidated. Furthermore,
binding partners from multiple tissues and cell lines may need to be obtained, given certain
nesprin variants have distinctive localisations and therefore probable altered scaffolding
functions in different cell lines.
Authors: R Mark Grady; Daniel A Starr; Gail L Ackerman; Joshua R Sanes; Min Han Journal: Proc Natl Acad Sci U S A Date: 2005-03-04 Impact factor: 11.205
Authors: Farhana Haque; David J Lloyd; Dawn T Smallwood; Carolyn L Dent; Catherine M Shanahan; Andrew M Fry; Richard C Trembath; Sue Shackleton Journal: Mol Cell Biol Date: 2006-05 Impact factor: 4.272
Authors: Juehua Yu; Daniel A Starr; Xiaohui Wu; Susan M Parkhurst; Yuan Zhuang; Tian Xu; Rener Xu; Min Han Journal: Dev Biol Date: 2005-12-07 Impact factor: 3.582
Authors: François Gros-Louis; Nicolas Dupré; Patrick Dion; Michael A Fox; Sandra Laurent; Steve Verreault; Joshua R Sanes; Jean-Pierre Bouchard; Guy A Rouleau Journal: Nat Genet Date: 2006-12-10 Impact factor: 38.330
Authors: Helen R Dawe; Matthew Adams; Gabrielle Wheway; Katarzyna Szymanska; Clare V Logan; Angelika A Noegel; Keith Gull; Colin A Johnson Journal: J Cell Sci Date: 2009-07-13 Impact factor: 5.285
Authors: Daniel A Balikov; Sonia K Brady; Ung Hyun Ko; Jennifer H Shin; Jose M de Pereda; Arnoud Sonnenberg; Hak-Joon Sung; Matthew J Lang Journal: Nucleus Date: 2017-06-22 Impact factor: 4.197
Authors: Zeinab Jahed; Darya Fadavi; Uyen T Vu; Ehsaneddin Asgari; G W Gant Luxton; Mohammad R K Mofrad Journal: Biophys J Date: 2018-03-13 Impact factor: 4.033